Megagliptin MF 20/500mg Tablet

Introduction to Megagliptin MF 20/500 mg Tablet

Megagliptin MF 20/500mg Tablets is a combination of Metformin and Teneligliptin which belongs to the group of medicines called Antidiabetic agents. It is used to treat Type II diabetes mellitus among patients when diet, exercise and treatment with other conventional medicines does not result in adequate control on blood glucose levels.

Type II diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood. It is caused due to inadequate production of a hormone called insulin (produced by pancreas to metabolize glucose) in the body or due to inadequate sensitivity of body cells to the actions of insulin.

Before taking Megagliptin MF 20/500mg Tablets inform your doctor if you have any liver, kidney or heart problems. You must also inform your doctor if you have low potassium levels in blood or are severely dehydrated due to excessive vomiting or diarrhea recently. Megagliptin MF 20/500mg Tablets are manufactured by Aristo Pharma.

During therapy with Megagliptin MF 20/500mg Tablets, your doctor might regularly monitor your blood sugar levels and kidney functions to avoid the risk of unwanted side effects. He/she might also ask you to make certain lifestyle changes such as following a healthy diet, regular physical exercise and quitting alcohol consumption to achieve better results.

Megagliptin MF 20/500mg Tablets is not recommended for use in patients with severe uncontrollable diabetes. It is also not suitable for use in patients with alcoholism and in patients with severe systemic infections.

Uses of Megagliptin MF 20/500mg

• Treats Type II Diabetesmellitus

How Does Megagliptin MF 20/500 Works?

Megagliptin MF 20/500mg Tablets is an antidiabetic medicine. It contains two medicines namely metformin and teneligliptin. Metformin makes the body more sensitive to insulin (a hormone involved in glucose metabolism). This helps our body cells to utilize more amount of the circulating blood glucose. Additionally, it can stop glucose production by the liver and reduces its absorption in the body.

Teneligliptin controls blood sugar levels by blocking the actions of an enzyme called Dipeptidyl Peptidase (DPP)-4 that reduces insulin secretion in the body. Collectively, Megagliptin MF 20/500mg Tablets controls blood sugar levels and improve glycemic control in patients with type II diabetes.

Side Effects of Megagliptin MF 20/500

Common Side Effects 

• Hypoglycemia (low blood sugar)
• Nausea, vomiting
• Flatulence, diarrhea, constipation, stomach pain, loss of appetite
• Headache, dizziness
• Changes in taste

How to Manage Side Effects?

• Contact Your Healthcare Provider
• Follow Prescribed Dosage
• Timing and Administration
• Stay Hydrated
• Monitor Blood Sugar Levels
• Avoid Alcohol and Certain Foods
• Reporting Side Effects
• Compliance with Medication

Warning & Precautions 

• Allergies
• Pregnancy and Breastfeeding
• Liver or Kidney Issues
• Blood Sugar Monitoring
• Avoid Alcohol
• Drug Interactions
• Age Restrictions
• Driving and Machinery

Safety Advice

• Prescription Only: “Megagliptin MF 20/500” is likely a prescription medication. Always take it under the guidance of a qualified healthcare professional.
• Dosage: Take “Megagliptin MF 20/500” as prescribed by your doctor. Do not exceed the recommended dosage or change the dosing schedule without medical supervision.
• Allergies: Inform your healthcare provider about any known allergies to medications or their ingredients before starting “Megagliptin MF 20/500.”
• Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of “Megagliptin MF 20/500” with your doctor.
• Liver or Kidney Issues: Inform your healthcare provider if you have a history of liver or kidney problems before taking “Megagliptin MF 20/500” or any new medication.

Frequently Asked Questions

1. Is it safe to use Megagliptin MF Tablet PR?

Ans. Yes, it is safe to use Megagliptin MF Tablet PR if you take it for the prescribed duration and according to the dosage advised by the doctor. However, despite taking the prescribed dosage you might experience common side effects like nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory tract infection and hypoglycemia (low blood sugar level). Hypoglycemia is relatively common in patients who are taking Megagliptin MF Tablet PR in combination with insulin or Sulfonylurea. Inform your doctor if you experience any persistent problem while taking this medicine.

2. Can the use of Megagliptin MF Tablet PR lead to hypoglycemia?

Ans. The use of Megagliptin MF Tablet PR does not usually cause hypoglycemia (low blood sugar level) on its own. But, it could occur if there is insufficient supplementation of calories while taking this medicine. Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. The symptoms are more likely to be noticed if you miss or delay your food, drink alcohol, over-exercise or take any other antidiabetic medicine along with it. Hence, regular monitoring of blood sugar level is important. It is recommended to always carry glucose tablets, honey or fruit juice with you.

3. Can the use of Megagliptin MF Tablet PR cause nausea and vomiting?

Ans. Yes, the use of Megagliptin MF Tablet PR can cause nausea and vomiting. In case of vomiting, drink plenty of water or other fluids by taking small frequent sips. Talk to your doctor if vomiting persists and you notice signs of dehydration, like dark colored and strong-smelling urine and a low frequency of urination. Do not take any other medicine without consulting a doctor.

4. Are there any specific contraindications associated with the use of Megagliptin MF Tablet PR?

Ans. The use of Megagliptin MF Tablet PR should be avoided in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine is also considered to be harmful for patients with severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis or diabetic ketoacidosis.